AKT1 and hepatocellular carcinoma: Up-regulation of AXL is well documented in hepatocellular carcinoma (HCC), and contributes to HCC cell line proliferation, migration and invasion [36–38], through activation of AKT and MAPK signalling pathways (reviewed in [39]).